Tencent has begun a clinical trial in London of an artificial intelligence program that aims to diagnose patients with Parkinson’s disease, in partnership with a little-known British start-up called Medopad.
The tech giant was
asked two years ago by the Chinese government to lead efforts to develop AI programs for medical diagnosis.
您已閱讀8%（332字），剩餘92%（3667字）包含更多重要資訊，訂閱以繼續探索完整內容，並享受更多專屬服務。